151-200 monitoring parametets

Question 1

Diflucan/Fluconzazole

Answer 1

Periodic LFTs and renal function tests
Potassium levels
Signs and symptoms hepatic injury sings of rash

Question 2

Flagyl/Metronidazole

Answer 2

Monitor CBC at baseline, during, and after PROLONGED treatment

Monitor elderly patinets with severe hepatic impairment or ERSD for adverse reactions

Neurological symptoms

Question 3

Gentamycin/Tobramycin

Answer 3

BOTH - Urinalysis, urine output, BUN, serum creatinine, plasma gentamicin levels, test hearing before, during, and after use

Question 4

Cephlexin/Keflex
Cefazolin/Kefzol

Answer 4

Prolonged therapy - monitor renal, hepatic, and hematologic function

Question 5

Lamisil/Tebrinafine

Answer 5

LFTs at baseline and periodically throughout treatment; monitor for signs of liver disease; CBC

Question 6

Levaquin/Levofloxacin

Answer 6

Closely monitor all vital organ systems; crystalluria, WBC, signs of fluoroquinolone toxicities

Question 7

Macrobid/Macrodantin
Nitrofurantoin

Answer 7

Signs of pulmonary toxicity; numbness and tingling in extremeities; periodic LFTs and renal functions with long term use

Question 8

Meropenem/Merrem

Answer 8

Cultures and sensitivity testing; on first dose monitor anaphylaxis signs; renal and hepatic function during use

Question 9

Fosfomycin/Monurol

Answer 9

Renal function
Electrolytes

Question 10

Moxifloxacin

Answer 10

WBC
Signs of infection
Signs of disordered glucose regulation
ECG in patients with cirrhosis

Question 11

Nafcillin

Answer 11

Renal function
CBC
Liver enzymes
Monitor for anaphylaxis during first dose

Question 12

Nystatin

Answer 12

N/A

Question 13

Cefdinir/Omnicef

Answer 13

Monitor renal function
Watch for anaphylaxis during first dose

Question 14

Rocephin/Ceftriaxone

Answer 14

Prothrombin/INR
Test of cure 7-14 days after initial treatment